SS

Shayam Sundar Chugh

Active Director Director DIN 09522779
DIN 09522779 First appointment Feb 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Shayam Sundar Chugh

Data last updated:

Shayam Sundar Chugh is a Director at Qrent Pharmaceuticals Private Limited (since 2022). The company operates in Healthcare. Qrent Pharmaceuticals Private Limited reported revenue of ₹13.9 Lakh (FY 2024).

DIN 09522779
Primary Designation Director
Industry Healthcare
First Appointment 28 Feb 2022
Oldest Company Age 4 yrs
Largest company Qrent Pharmaceuticals Private Limited · ₹13.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Feb 20222022₹13.9 Lakh (FY 2024)Active

Board colleagues of Shayam Sundar Chugh

NameDINCompanyDesignation
Manish Chugh09522778Qrent Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Qrent Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shayam Sundar Chugh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shayam Sundar Chugh

Shayam Sundar Chugh currently holds 1 directorship: Qrent Pharmaceuticals Private Limited (Director, since 28 Feb 2022, revenue ₹13.9 Lakh (FY 2024)).

Shayam Sundar Chugh was first appointed on 28 Feb 2022 as Director at Qrent Pharmaceuticals Private Limited.

The current boards of Shayam Sundar Chugh's companies include Manish Chugh (Qrent Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available